Member

This is about ensuring that patients have a chance to understand how widely varying their future might be and that clinical predictions of life expectancy show wide variability, depending on the condition that they have or the method that has been used to calculate it. For example, I think it is important that female patients are told that women with terminal cancer tend to survive longer than men, yet prognoses are rarely disaggregated by sex. Tell women—“That’ll cheer you up”—but maybe do not tell the men.